| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| TGTXTG Therapeutics, Inc. | 4.75B | 30.09 | 200.60 | 40.8% | 13.31% | 21.87% | 1.14 | |
| APLSApellis Pharmaceuticals, Inc. | 2.65B | 20.96 | 116.44 | -11.77% | 3.25% | 7.48% | 1.71% | 0.30 |
| ARGXargenx SE | 47.46B | 766.92 | 60.01 | 78.6% | 23.34% | 15.14% | 0.01 | |
| KNSAKiniksa Pharmaceuticals, Ltd. | 3.39B | 44.49 | 59.32 | 60.09% | 17.52% | 20.92% | 0.75% | 0.02 |
| AUPHAurinia Pharmaceuticals Inc. | 1.88B | 14.17 | 6.85 | 20.38% | 101.47% | 49.4% | 7.22% | 0.13 |
| GLPGGalapagos N.V. | 2.22B | 33.66 | 5.88 | 303.48% | 28.85% | 9.92% | 0.00 | |
| AKTXAkari Therapeutics, Plc | 12.56B | 0.24 | -0.00 | -69.35% | 0.15 | |||
| RAPTRAPT Therapeutics, Inc. | 7.65B | 57.98 | -2.27 | -69.51% | 0.02 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 5.04M | 3.81M | 1.53M | 0 | 0 |
| Revenue Growth % | - | - | - | - | -24.38% | -59.95% | -100% | - |
| Cost of Goods Sold | 1.38M | 1.24M | 1.33M | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - |
| Gross Profit | -1.38M | -1.24M | -1.33M | 5.04M | 3.81M | 1.53M | 0 | 0 |
| Gross Margin % | - | - | - | 100% | 100% | 100% | - | - |
| Gross Profit Growth % | - | 10.62% | -7.52% | 479.1% | -24.38% | -59.95% | -100% | - |
| Operating Expenses | 29.33M | 36.95M | 43.63M | 58.26M | 73.02M | 87.32M | 127.06M | 136.1M |
| OpEx % of Revenue | - | - | - | 1155.41% | 1915.08% | 5718.53% | - | - |
| Selling, General & Admin | 3.71M | 5.18M | 8.72M | 12.77M | 16.04M | 20.24M | 26.06M | 28.88M |
| SG&A % of Revenue | - | - | - | 253.29% | 420.59% | 1325.47% | - | - |
| Research & Development | 25.62M | 31.77M | 34.91M | 45.48M | 56.98M | 67.08M | 101M | 107.22M |
| R&D % of Revenue | - | - | - | 902.12% | 1494.49% | 4393.06% | - | - |
| Other Operating Expenses | 216K | 800K | 1.29M | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -29.33M | -36.95M | -43.63M | -53.21M | -69.21M | -85.8M | -127.06M | -136.1M |
| Operating Margin % | - | - | - | -1055.41% | -1815.08% | -5618.53% | - | - |
| Operating Income Growth % | - | -25.97% | -18.09% | -21.97% | -30.06% | -23.97% | -48.1% | -7.11% |
| EBITDA | -27.95M | -35.71M | -42.3M | -52.09M | -68.21M | -84.75M | -125.85M | -134.9M |
| EBITDA Margin % | - | - | - | -1033.14% | -1788.96% | -5549.97% | - | - |
| EBITDA Growth % | - | -27.78% | -18.45% | -23.15% | -30.95% | -24.24% | -48.49% | -7.19% |
| D&A (Non-Cash Add-back) | 1.38M | 1.24M | 1.33M | 1.12M | 996K | 1.05M | 1.22M | 1.2M |
| EBIT | -29.33M | -36.95M | -43.63M | -53.21M | -69.21M | -85.8M | -127.06M | -136.1M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 216K | 800K | 1.29M | 1.31M | 5K | 1.96M | 10.26M | 6.24M |
| Pretax Income | -29.11M | -36.15M | -42.34M | -51.9M | -69.2M | -83.84M | -116.8M | -129.87M |
| Pretax Margin % | - | - | - | -1029.39% | -1814.95% | -5490.37% | - | - |
| Income Tax | 0 | 0 | 660K | 990K | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 100% | 100% | 101.56% | 101.91% | 100% | 100% | 100% | 100% |
| Net Income | -29.11M | -36.15M | -43M | -52.89M | -69.2M | -83.84M | -116.8M | -129.87M |
| Net Margin % | - | - | - | -1049.03% | -1814.95% | -5490.37% | - | - |
| Net Income Growth % | - | -24.15% | -18.95% | -23.01% | -30.84% | -21.15% | -39.31% | -11.19% |
| Net Income (Continuing) | -29.11M | -36.15M | -43M | -52.89M | -69.2M | -83.84M | -116.8M | -129.87M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -10.95 | -13.59 | -15.75 | -17.53 | -20.21 | -20.61 | -24.37 | -25.49 |
| EPS Growth % | - | -24.15% | -15.94% | -11.28% | -15.29% | -1.97% | -18.25% | -4.58% |
| EPS (Basic) | -10.95 | -13.59 | -15.75 | -17.53 | -20.21 | -20.61 | -24.37 | -25.49 |
| Diluted Shares Outstanding | 2.66M | 2.66M | 2.73M | 3.02M | 3.42M | 4.07M | 4.79M | 5.1M |
| Basic Shares Outstanding | 2.66M | 2.66M | 2.73M | 3.02M | 3.42M | 4.07M | 4.79M | 5.1M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 48.24M | 65.06M | 80.51M | 115.6M | 192.97M | 252.69M | 161.78M | 235.24M |
| Cash & Short-Term Investments | 47.52M | 63.8M | 77.38M | 111.51M | 189.65M | 249.07M | 158.86M | 231.06M |
| Cash Only | 47.52M | 63.8M | 77.38M | 24.92M | 24.03M | 38.95M | 47.48M | 169.74M |
| Short-Term Investments | 0 | 0 | 0 | 86.59M | 165.63M | 210.12M | 111.38M | 61.32M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 4.09M | 3.32M | 3.63M | 2.92M | 4.18M |
| Total Non-Current Assets | 2.15M | 4.55M | 4.1M | 3.37M | 5.66M | 13.52M | 11.55M | 5.09M |
| Property, Plant & Equipment | 1.91M | 4.16M | 3.71M | 2.98M | 2.74M | 9.48M | 7.68M | 4.7M |
| Fixed Asset Turnover | - | - | - | 1.69x | 1.39x | 0.16x | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 605K | 598K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | -369K | -209K | 389K | 389K | 2.92M | 4.04M | 3.87M | 389K |
| Total Assets | 50.39M | 69.61M | 84.6M | 118.97M | 198.64M | 266.21M | 173.33M | 240.32M |
| Asset Turnover | - | - | - | 0.04x | 0.02x | 0.01x | - | - |
| Asset Growth % | - | 38.14% | 21.54% | 40.62% | 66.96% | 34.02% | -34.89% | 38.65% |
| Total Current Liabilities | 3.25M | 4.64M | 9.26M | 11.74M | 9.6M | 14.22M | 21.84M | 48.35M |
| Accounts Payable | 1.11M | 1.77M | 1.14M | 2.38M | 2M | 3.37M | 5.18M | 1.27M |
| Days Payables Outstanding | 291.68 | 522.57 | 313.68 | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 4M | 4.1M | 1.02M | 0 | 0 | 0 |
| Other Current Liabilities | 650K | 586K | 2.25M | 2.3M | 2.93M | 4.65M | 7.91M | 6.78M |
| Current Ratio | 14.85x | 14.01x | 8.70x | 9.84x | 20.11x | 17.77x | 7.41x | 4.87x |
| Quick Ratio | 14.85x | 14.01x | 8.70x | 9.84x | 20.11x | 17.77x | 7.41x | 4.87x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 109.55M | 969K | 2.23M | 3.05M | 2.66M | 6.82M | 4.46M | 2.07M |
| Long-Term Debt | 108.64M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 6.82M | 4.46M | 2.07M |
| Deferred Tax Liabilities | -108.64M | -162.08M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 905K | 969K | 2.23M | 2.19M | 2.15M | 0 | 0 | 0 |
| Total Liabilities | 112.8M | 5.61M | 11.48M | 14.79M | 12.26M | 21.04M | 26.29M | 50.42M |
| Total Debt | 108.64M | 161.11M | 0 | 0 | 0 | 8.99M | 6.91M | 4.49M |
| Net Debt | 61.13M | 97.31M | -77.38M | -24.92M | -24.03M | -29.96M | -40.57M | -165.24M |
| Debt / Equity | - | 2.52x | - | - | - | 0.04x | 0.05x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - |
| Total Equity | -62.41M | 64M | 73.12M | 104.18M | 186.38M | 245.17M | 147.03M | 189.9M |
| Equity Growth % | - | 202.55% | 14.26% | 42.47% | 78.9% | 31.54% | -40.03% | 29.16% |
| Book Value per Share | -23.46 | 24.06 | 26.79 | 34.53 | 54.44 | 60.27 | 30.68 | 37.27 |
| Total Shareholders' Equity | -62.41M | 64M | 73.12M | 104.18M | 186.38M | 245.17M | 147.03M | 189.9M |
| Common Stock | 1K | 2K | 2K | 2K | 3K | 3K | 3K | 13K |
| Retained Earnings | -82.81M | -118.95M | -161.95M | -214.84M | -284.05M | -367.88M | -484.68M | -614.55M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -3.77M | -4K | 20K | -177K | -206K | -26K | 103K | 50K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -27.12M | -32.95M | -35.47M | -40.49M | -61.03M | -70.77M | -97.05M | -83.3M |
| Operating CF Margin % | - | - | - | -803.07% | -1600.47% | -4634.64% | - | - |
| Operating CF Growth % | - | -21.49% | -7.65% | -14.14% | -50.71% | -15.97% | -37.13% | 14.17% |
| Net Income | -29.11M | -36.15M | -43M | -52.89M | -69.2M | -83.84M | -116.8M | -129.87M |
| Depreciation & Amortization | 1.38M | 1.24M | 1.33M | 1.12M | 996K | 1.05M | 3.55M | 1.2M |
| Stock-Based Compensation | 716K | 1.17M | 2.05M | 8.69M | 9.95M | 11.26M | 0 | 19.93M |
| Deferred Taxes | 15K | 17K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -9K | -14K | 9K | 248K | 1.53M | 2.09M | 10.7M | -477K |
| Working Capital Changes | -114K | 784K | 4.13M | 2.34M | -4.3M | -1.33M | 5.5M | 25.91M |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -80K | 1.48M | 736K | 2.39M | 933K | 3.71M | 7.33M | -8.46M |
| Cash from Investing | -1.12M | -3.5M | -843K | -87.44M | -81.35M | -45.49M | 104.13M | 52.7M |
| Capital Expenditures | -1.12M | -3.5M | -888K | -398K | -755K | -845K | -1.13M | -122K |
| CapEx % of Revenue | - | - | - | 7.89% | 19.8% | 55.34% | - | - |
| Acquisitions | 0 | 0 | 0 | 87.04M | 80.59M | 44.65M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 45K | -87.04M | -80.59M | -44.65M | 0 | 0 |
| Cash from Financing | 30.1M | 52.73M | 49.9M | 75.46M | 141.48M | 131.18M | 1.45M | 152.85M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 30.1M | 52.73M | 0 | 1.85M | 2.02M | 1.39M | 0 | 845K |
| Net Change in Cash | 1.85M | 16.28M | 13.59M | -52.47M | -891K | 14.92M | 8.53M | 122.26M |
| Free Cash Flow | -28.25M | -36.45M | -36.36M | -40.89M | -61.78M | -71.62M | -98.17M | -83.42M |
| FCF Margin % | - | - | - | -810.97% | -1620.27% | -4689.98% | - | - |
| FCF Growth % | - | -29.05% | 0.25% | -12.45% | -51.09% | -15.92% | -37.08% | 15.03% |
| FCF per Share | -10.62 | -13.70 | -13.32 | -13.55 | -18.04 | -17.61 | -20.49 | -16.37 |
| FCF Conversion (FCF/Net Income) | 0.93x | 0.91x | 0.83x | 0.77x | 0.88x | 0.84x | 0.83x | 0.64x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 660K | 990K | 0 | 0 | 0 | 0 |
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | -4538.23% | -62.71% | -59.66% | -47.64% | -38.85% | -59.56% | -77.09% |
| Return on Invested Capital (ROIC) | - | -34.63% | -41.67% | -106.43% | -42.97% | -34.09% | -59.25% | -155.69% |
| Gross Margin | - | - | - | 100% | 100% | 100% | - | - |
| Net Margin | - | - | - | -1049.03% | -1814.95% | -5490.37% | - | - |
| Debt / Equity | - | 2.52x | - | - | - | 0.04x | 0.05x | 0.02x |
| FCF Conversion | 0.93x | 0.91x | 0.83x | 0.77x | 0.88x | 0.84x | 0.83x | 0.64x |
| Revenue Growth | - | - | - | - | -24.38% | -59.95% | -100% | - |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics